Emily Darlington Alert Sample


Alert Sample

View the Parallel Parliament page for Emily Darlington

Information between 10th December 2024 - 20th December 2024

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.


Division Votes
9 Dec 2024 - Terrorism (Protection of Premises) Bill - View Vote Context
Emily Darlington voted No - in line with the party majority and in line with the House
One of 335 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 89 Noes - 340
10 Dec 2024 - Delegated Legislation - View Vote Context
Emily Darlington voted Aye - in line with the party majority and in line with the House
One of 339 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 424 Noes - 106
10 Dec 2024 - Finance Bill - View Vote Context
Emily Darlington voted No - in line with the party majority and in line with the House
One of 345 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 184 Noes - 359
10 Dec 2024 - Finance Bill - View Vote Context
Emily Darlington voted No - in line with the party majority and in line with the House
One of 327 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 105 Noes - 340
10 Dec 2024 - Finance Bill - View Vote Context
Emily Darlington voted No - in line with the party majority and in line with the House
One of 341 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 74 Noes - 350
17 Dec 2024 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context
Emily Darlington voted Aye - in line with the party majority and in line with the House
One of 345 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 354 Noes - 202
17 Dec 2024 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context
Emily Darlington voted No - in line with the party majority and in line with the House
One of 346 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 195 Noes - 353
17 Dec 2024 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context
Emily Darlington voted No - in line with the party majority and in line with the House
One of 345 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 196 Noes - 352
17 Dec 2024 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context
Emily Darlington voted No - in line with the party majority and in line with the House
One of 347 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 206 Noes - 353
17 Dec 2024 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context
Emily Darlington voted No - in line with the party majority and in line with the House
One of 346 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 100 Noes - 351
11 Dec 2024 - Finance Bill - View Vote Context
Emily Darlington voted Aye - in line with the party majority and in line with the House
One of 313 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 338 Noes - 170
11 Dec 2024 - Finance Bill - View Vote Context
Emily Darlington voted Aye - in line with the party majority and in line with the House
One of 311 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 332 Noes - 170
11 Dec 2024 - Trade - View Vote Context
Emily Darlington voted Aye - in line with the party majority and in line with the House
One of 298 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 375 Noes - 9


Speeches
Emily Darlington speeches from: Provisional Local Government Finance Settlement
Emily Darlington contributed 1 speech (115 words)
Wednesday 18th December 2024 - Commons Chamber
Ministry of Housing, Communities and Local Government
Emily Darlington speeches from: Puberty-suppressing Hormones
Emily Darlington contributed 1 speech (180 words)
Wednesday 11th December 2024 - Commons Chamber
Department of Health and Social Care



Emily Darlington - Select Committee Information

Calendar
Tuesday 17th December 2024 9 a.m.
Science, Innovation and Technology Committee - Oral evidence
Subject: Innovation showcase
At 9:30am: Oral evidence
Marie Labus - CEO at AMLo Biosciences
At 9:45am: Oral evidence
Professor David Lalloo - Vice-Chancellor at Liverpool School of Tropical Medicine
Dr Lisa Stockdale - Senior Immunologist at The Jenner Institute
At 10:20am: Oral evidence
Professor Siddharthan Chandran - Director at The UK Dementia Research Institute
Dr Simon Stott - Director of Research at Cure Parkinson's
At 10:55am: Oral evidence
Professor Ketan Patel - Chief Scientist at Cancer Research UK
Dr Julie Torode - Director of Strategic Partnerships at Institute of Cancer Policy, Kings College London
View calendar
Tuesday 7th January 2025 9 a.m.
Science, Innovation and Technology Committee - Private Meeting
View calendar


Select Committee Documents
Tuesday 17th December 2024
Correspondence - Correspondence from Secretary of State and Permanent Secretary of the Department for Science, Innovation and Technology, in relation to a breakdown of R&D expenditure across Government, dated 20 November 2024

Science, Innovation and Technology Committee
Tuesday 17th December 2024
Correspondence - Correspondence from Secretary of State of the Department for Science, Innovation and Technology, in relation to the Online Safety Act: Draft Statutory Instrument, dated 13 December 2024

Science, Innovation and Technology Committee
Tuesday 17th December 2024
Correspondence - Correspondence from The Royal Society in relation a to follow-up from budget 2024 oral evidence session and potential topics for future inquiries, dated 3 December 2024

Science, Innovation and Technology Committee
Tuesday 17th December 2024
Oral Evidence - AMLo Biosciences

Innovation showcase - Science, Innovation and Technology Committee


Select Committee Inquiry
6 Dec 2024
Innovation, growth and the regions
Science, Innovation and Technology Committee (Select)

Submit Evidence (by 13 Jan 2025)


The Science, Innovation and Technology Select Committee is launching an inquiry into “Innovation, growth and the regions” to assess the role of the UK’s innovation ecosystem in achieving the Government’s mission to kickstart economic growth across the country.

The inquiry will consider the role of structural factors—such as the tax system, regulatory requirements, and standards—in influencing the success of start-ups, spin-outs, and other innovation-focused enterprises.  The Committee will assess the health of the country’s innovation ecosystem across the nations and regions. It will look at the interplay of local and national government policy, access to investment, research clusters, and infrastructure in fostering innovation and making the regions an engine for growth.

It will explore how universities and businesses work together to commercialise research and to tackle obstacles such as funding and market access. It will evaluate the link between innovation and economic growth both regionally and nationally, drawing lessons from international comparators and considering the impact of regional clusters and hubs, including the Catapult network.